Lynparza® (2018-02-23)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type III
| Lot or serial number | Brand name | Companies | Dosage form | DIN, NPN, DIN-HIM | Strength |
|---|
| NG944, NG695, NK349 | Lynparza® | - Recalling Firm
- AstraZeneca Canada Inc.
- 1004 Middlegate Road
- Mississauga
- L4Y 1M4
- Ontario
- CANADA
- Marketing Authorization Holder
- AstraZeneca Canada Inc.
- 1004 Middlegate Road
- Mississauga
- L4Y 1M4
- Ontario
- CANADA
| Capsules | DIN 02454408 | 50 MG |
Affected Products
Lynparza®
During on-going stability monitoring, an out of specification was found with the listed product lots.